KGLDF yields 476.19% · JNJ yields 2.13%● Live data
📍 KGLDF pulled ahead of the other in Year 1
Combined, KGLDF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KGLDF + JNJ for your $10,000?
King Global Ventures Inc., a junior prospecting and natural-resource company, engages in the acquisition and exploration of mineral properties. The company focuses on gold exploration in Newfoundland. It holds a 100% interest in the York Gold project comprising 77 claims situated in northeastern Quebec; the Boulder Gold property that consists of four contiguous claim blocks of 100 hectares located in Central Newfoundland; and the Golden Nugget property that consists of a 10-kilometer-long contiguous land package of 1850 hectares located in the north of the Davidsville group. The company also holds a 100% interest in the Miss Pickle Island property that consists of 950 hectares located in the Dunnage Coaker Corridor; and the Chapel Island property comprises 54 mining claims situated in northeast-central Newfoundland. The company was formerly known as Rosita Mining Corporation and changed its name to King Global Ventures Inc. in September 2019. King Global Ventures Inc. is headquartered in Toronto, Canada.
Full KGLDF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.